TBAT Innovation Ltd are pleased to announce the return of the Innovate UK Biomedical Catalyst Awards for 2019. The Round 1 competitions opened on 21st January 2019.
The Biomedical Catalyst has 4 funding strands to support progression of projects from initial concept through to late stage development:
- Early stage
- Late stage
For this round – all 4 stages are open for applications, which differs, as previously, only 2 of the 4 strands were open at a time!
The aim of the Biomedical Catalyst is to support the development of innovative healthcare products, technologies and processes. These can include (but are not limited to):
- disease prevention and proactive management of health and chronic conditions
- earlier and better detection and diagnosis of disease, leading to better patient outcomes
- tailored treatments that either change the underlying disease or offer potential cures
Biomedical Catalyst grant support is available for any life science sector or discipline, including (but not limited to):
- medical technologies and devices
- stratified healthcare
- advanced therapies (gene and cell therapies)
- digital health
- drug discovery
For Feasibility and Primer Awards, project costs can be between £50,000 and £1 million, with up to 70% funding. For more information on eligibility and scope – please click here.
For Early and Late Stage Awards, project costs can be between £250,000 and £4 million, with up to 70% funding. For more information on eligibility and scope – please click here.
Closing date for all 4 strands is 3rd April 2019.
If you are interested in applying and require TBAT’s expert support in writing and submitting your application, please don’t hesitate to get in touch so we can begin supporting your project planning.
T. 01332 819740